Biotech Faces Up to Our Own Leadership Diversity Challenge

Disease is an equal-opportunity enemy. It strikes men and women; children and seniors; and people of every race, ethnicity and nationality. It’s hard to imagine an industry with a more diverse customer base than the biotechnology companies creating next-generation cures for patients around the world.
Yet too often, the leadership ranks of our innovative companies are skewed overwhelmingly male. Nationally, only 10 percent of board of director slots and 7 to 9 percent of CEO positions at bi